Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer				Phase II, Phase I				UCIRB #14735B GV-001.010 (TNF-ELF), NCT00496236
	Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer				Phase II				06U.195 NCT00358007
	Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer				Phase II				08-050 NCT00713219
	A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients				Phase I				05C.255 NCT00329589
	Vaccine Therapy in Treating Patients With Head and Neck Cancer				Phase I				PCI-03-156 PCI-0507062, NCT00404339
	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients				Phase I				06C.549 NCT00437372
	Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer				Phase I				RPCI-I-74606 NCT00470496
	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck				Phase I				H-29776 UMGCC 0804, NCT00704041
	Early Physical Therapy in Improving Physical and Functional Well-Being in Head and Neck Cancer Survivors Receiving Chemoradiotherapy				Phase I				VU-VICC-SUPP-0843 VICCSUPP0843, NCT00751816
	Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy				No phase specified				02-05-127E NIH-R21-CA104402, NCT00200486


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute